TP53 and lung adenocarcinoma: C57BL/6J mice were treated with ABx or sterile water for 2 weeks before tumor injection, and then 1 × 106 OVA-expressing, Kras-mutated, Tp53-deficient lung adenocarcinoma (KPOVA) cells were inoculated intrathoracically.